Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|14|8|685-699

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.14, Iss.8, 2014-10, pp. : 685-699

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein

By  

Current Medicinal Chemistry, Vol. 24, Iss. 40, 2018-01 ,pp. : 4488-4514

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular Regulation of SIRT1

By  

Current Pharmaceutical Design, Vol. 15, Iss. 1, 2009-01 ,pp. : 39-44

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of Sirt1 Decreases Adipocyte Formation during Osteoblast Differentiation of Mesenchymal Stem Cells

By  

Cells Tissues Organs, Vol. 189, Iss. 1-4, 2008-08 ,pp. : 93-97

Karger

Access to resources Recommend Favorite

Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review

By Pulla Venkat Koushik   Battu Madhu Babu   Alvala Mallika   Sriram Dharmarajan   Yogeeswari Perumal  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. : 819-832

Informa Healthcare

Access to resources Recommend Favorite

Physiological and Pathophysiological Functions of SIRT1

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-03 ,pp. : 386-394

Bentham Science Publishers

Access to resources Recommend Favorite